Cancer Drug

Study shows bacterial vaccine may serve as cancer immunotherapy treatment

The bacterial vaccine proved to be particularly more efficacious than peptide-based therapeutic cancer vaccines

3 cancer drugs now exempt from customs duty; X-ray tubes to become cheaper

The Union minister also brought down the customs duty on X-ray tubes used in medical X-ray machines

State regulators asked to withdraw marketing of cancer drug Olaparib

Manufacturer AstraZeneca Pharma India says its study shows drug may have detrimental effect

Many cancer drugs remain unproven 5 yrs after accelerated approval: Study

The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years. Five years after the initial accelerated approval, you should have a definitive answer, said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. Thousands of people are getting those drugs. That seems a mistake if we don't know whether they work or not." The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs. It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce

Rs 100 tablet to prevent resurgence of cancer: All you need to know

This new pill will reduce the side effects of cancer treatment like chemotherapy by about 50 per cent and the chances of getting cancer for a second time by 30 per cent

Alembic Pharmaceuticals gets USFDA nod to market generic cancer drug

The company's product is therapeutically equivalent to AstraZeneca UK's Calquence Capsules (100 mg)

Lupin gets USFDA approval to market generic cancer treatment drug

Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America. The company in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, it said in a statement. The Mumbai-based drug maker's product is a generic version of Bristol-Myers Squibb Company's Sprycel tablets. As per IQVIA MAT data, Dasatinib tablets had an estimated annual sale of USD 1,569 million in the US. Shares of Lupin settled at Rs 662.50 apiece, up 1.49 per cent on the BSE.

Zydus Cadila gets tentative approval from USFDA to market cancer drug

Drug firm Zydus Cadila on Wednesday said it has received tentative approval from the US health regulator to market Ibrutinib tablets used in the treatment of certain types of cancers.

Cipla settles blood cancer drug litigation with Bristol Myers in US

As it takes away the legal overhang, Cipla can launch the drug once its ANDA is approved

AstraZeneca agrees to pay Japan's Daiichi $6 bn for new cancer drug

The UK drugmaker will pay Japan's Daiichi $1 billion upfront to jointly develop and bring to market a cancer therapy in early clinical tests called DS-1062, the companies said

Cancer drug: Roche, Blueprint ink $1.7-bn deal after gene testing advances

US company Blueprint, which has been working with Roche since 2016, could also receive up to $927 million in milestone payments, plus royalties on sales outside the United States

Dr Reddy's launches cancer drug Abiraterone Acetate in US market

The drug is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson

How a residential home provider is coming to aid of child cancer patients

The study has found that the environment plays a statistically significant role in outcomes of cancers like acute leukaemia which need intensive treatment

Cancer now a bigger killer than heart diseases in rich nations: Study

It determined that people in poorer nations were on average 2.5 times more likely to die from heart disease than those in richer ones

A drug that can cure cancer without chemotherapy and side effects!

The complex biological medicines, called antibody drug conjugates (ADCs), have been in development for decades

NPPA slashes prices of 390 cancer drugs; move to benefit 22 lakh patients

All companies have been asked to ensure that the price caps are adhered to.

Govt slashes price of 390 non-scheduled cancer medicines by up to 87%

This move is expected to benefit 22 lakh cancer patients in the country and would result in annual savings of around Rs 800 crore to the patients

China agrees to lift tariffs on import of cancer drugs from India

However, it is not yet clear whether China has agreed to grant licences to Indian companies to sell cancer drug in the huge market

Intas launches chemotherapy drug at affordable price

It is estimated that every year over 700,000 patients die due to various types of cancer in India

Cancer drug: Supreme Court allows Cipla to withdraw appeal against Roche

The single judge had also refused to revoke the patent of the Swiss company as sought by Cipla